GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Gross Margin %

Abaxis (Abaxis) Gross Margin % : 54.96% (As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Abaxis's Gross Profit for the three months ended in Mar. 2018 was $37.3 Mil. Abaxis's Revenue for the three months ended in Mar. 2018 was $67.9 Mil. Therefore, Abaxis's Gross Margin % for the quarter that ended in Mar. 2018 was 54.96%.


The historical rank and industry rank for Abaxis's Gross Margin % or its related term are showing as below:


ABAX's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 45.595
* Ranked among companies with meaningful Gross Margin % only.

Abaxis had a gross margin of 54.96% for the quarter that ended in Mar. 2018 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Abaxis was 0.00% per year.


Abaxis Gross Margin % Historical Data

The historical data trend for Abaxis's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Gross Margin % Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.81 53.79 56.30 55.38 54.60

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.30 54.83 54.65 53.92 54.96

Competitive Comparison of Abaxis's Gross Margin %

For the Diagnostics & Research subindustry, Abaxis's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Abaxis's Gross Margin % falls into.



Abaxis Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Abaxis's Gross Margin for the fiscal year that ended in Mar. 2018 is calculated as

Gross Margin % (A: Mar. 2018 )=Gross Profit (A: Mar. 2018 ) / Revenue (A: Mar. 2018 )
=133.6 / 244.7
=(Revenue - Cost of Goods Sold) / Revenue
=(244.7 - 111.091) / 244.7
=54.60 %

Abaxis's Gross Margin for the quarter that ended in Mar. 2018 is calculated as


Gross Margin % (Q: Mar. 2018 )=Gross Profit (Q: Mar. 2018 ) / Revenue (Q: Mar. 2018 )
=37.3 / 67.918
=(Revenue - Cost of Goods Sold) / Revenue
=(67.918 - 30.59) / 67.918
=54.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Abaxis  (NAS:ABAX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Abaxis had a gross margin of 54.96% for the quarter that ended in Mar. 2018 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Abaxis Gross Margin % Related Terms

Thank you for viewing the detailed overview of Abaxis's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020